What's new in immunostimulating strategies in the ICU

Attenuated hemodynamic response to adjunct vasopressin in obese septic shock patients: a physiological or dose-dependent effect?

Critical care (London, England)·2026

State of the art: Renal recovery after AKI - from basic science to clinical practice.

Intensive care medicine·2025

Systemic inflammation impairs myelopoiesis and interferon type I responses in humans.

Nature immunology·2025

Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future.

Intensive care medicine experimental·2025

Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.

Cells·2024

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).

Intensive care medicine·2024

Impact of a strategy using multiplex PCR on targeted antibiotic therapy for patients with suspected ventilator-associated pneumonia or hospital-acquired pneumonia requiring mechanical ventilation: a randomized, single-blind trial.

Intensive care medicine·2026

Respiratory mechanics modifies the impact of ventilator settings on clinical outcome in patients with acute brain injury.

Intensive care medicine·2026

Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial.

Intensive care medicine·2026

ARDS management beyond the guidelines: a practical physiology-based approach to individualized care.

Intensive care medicine·2026

Corticosteroids in ARDS: old controversies, new insights, and future directions.

Intensive care medicine·2026

Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.

Intensive care medicine·2026

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

European journal of haematology·2026

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Immunotherapy·2026

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Frontiers in cellular and infection microbiology·2026

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Cureus·2026

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Frontiers in immunology·2026

Related Experiment Videos

What's new in immunostimulating strategies in the ICU

Related Concept Videos

Attenuated hemodynamic response to adjunct vasopressin in obese septic shock patients: a physiological or dose-dependent effect?

State of the art: Renal recovery after AKI - from basic science to clinical practice.

Systemic inflammation impairs myelopoiesis and interferon type I responses in humans.

Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future.

Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).

Impact of a strategy using multiplex PCR on targeted antibiotic therapy for patients with suspected ventilator-associated pneumonia or hospital-acquired pneumonia requiring mechanical ventilation: a randomized, single-blind trial.

Respiratory mechanics modifies the impact of ventilator settings on clinical outcome in patients with acute brain injury.

Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial.

ARDS management beyond the guidelines: a practical physiology-based approach to individualized care.

Corticosteroids in ARDS: old controversies, new insights, and future directions.

Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Related Experiment Videos

What's new in immunostimulating strategies in the ICU

Related Concept Videos

Related Articles